Farce A - Search Results

1

SINAPs: A Software Tool for Analysis and Visualization of Interaction Networks of Molecular Dynamics Simulations.

Bedart C, Renault N, Chavatte P, Porcherie A, Lachgar A, Capron M, Farce A. Bedart C, et al. Among authors: farce a. J Chem Inf Model. 2022 Mar 28;62(6):1425-1436. doi: 10.1021/acs.jcim.1c00854. Epub 2022 Mar 3. J Chem Inf Model. 2022. PMID: 35239339 Free PMC article.

2

Docking study of ligands into the colchicine binding site of tubulin.

Farce A, Loge C, Gallet S, Lebegue N, Carato P, Chavatte P, Berthelot P, Lesieur D. Farce A, et al. J Enzyme Inhib Med Chem. 2004 Dec;19(6):541-7. doi: 10.1080/14756360412331280545. J Enzyme Inhib Med Chem. 2004. PMID: 15662957

3

Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

Stern E, Muccioli GG, Millet R, Goossens JF, Farce A, Chavatte P, Poupaert JH, Lambert DM, Depreux P, Hénichart JP. Stern E, et al. Among authors: farce a. J Med Chem. 2006 Jan 12;49(1):70-9. doi: 10.1021/jm050467q. J Med Chem. 2006. PMID: 16392793

4

Identification of a pharmacophore of SKCa channel blockers.

Dilly S, Graulich A, Farce A, Seutin V, Liegeois JF, Chavatte P. Dilly S, et al. Among authors: farce a. J Enzyme Inhib Med Chem. 2005 Dec;20(6):517-23. doi: 10.1080/14756360500210989. J Enzyme Inhib Med Chem. 2005. PMID: 16408787

5

Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.

Gilleron P, Millet R, Houssin R, Wlodarczyk N, Farce A, Lemoine A, Goossens JF, Chavatte P, Pommery N, Hénichart JP. Gilleron P, et al. Among authors: farce a. Eur J Med Chem. 2006 Jun;41(6):745-55. doi: 10.1016/j.ejmech.2006.03.017. Epub 2006 May 2. Eur J Med Chem. 2006. PMID: 16647166

6

A computational view of COX-2 inhibition.

Chavatte P, Farce A. Chavatte P, et al. Among authors: farce a. Anticancer Agents Med Chem. 2006 May;6(3):239-49. doi: 10.2174/187152006776930909. Anticancer Agents Med Chem. 2006. PMID: 16712452 Review.

7

Homology modelling of the serotoninergic 5-HT2c receptor.

Farce A, Dilly S, Yous S, Berthelot P, Chavatte P. Farce A, et al. J Enzyme Inhib Med Chem. 2006 Jun;21(3):285-92. doi: 10.1080/14756360600700608. J Enzyme Inhib Med Chem. 2006. PMID: 16918076

8

Differences in binding sites of two melatonin receptors help to explain their selectivity to some melatonin analogs: a molecular modeling study.

Chugunov AO, Farce A, Chavatte P, Efremov RG. Chugunov AO, et al. Among authors: farce a. J Biomol Struct Dyn. 2006 Oct;24(2):91-107. doi: 10.1080/07391102.2006.10507103. J Biomol Struct Dyn. 2006. PMID: 16928133

9

Quantitative structure-activity relationships studies of antioxidant hexahydropyridoindoles and flavonoid derivatives.

Durand AC, Farce A, Carato P, Dilly S, Yous S, Berthelot P, Chavatte P. Durand AC, et al. Among authors: farce a. J Enzyme Inhib Med Chem. 2007 Oct;22(5):556-62. doi: 10.1080/14756360701425238. J Enzyme Inhib Med Chem. 2007. PMID: 18035823

10

Homology modeling of MT1 and MT2 receptors.

Farce A, Chugunov AO, Logé C, Sabaouni A, Yous S, Dilly S, Renault N, Vergoten G, Efremov RG, Lesieur D, Chavatte P. Farce A, et al. Eur J Med Chem. 2008 Sep;43(9):1926-44. doi: 10.1016/j.ejmech.2007.12.001. Epub 2007 Dec 14. Eur J Med Chem. 2008. PMID: 18255198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page